(S (NP (NP (DT A) (JJ major) (NN barrier)) (PP (TO to) (NP (NP (JJ medical) (NN imaging) (NN research)) (CC and) (NP (PP (IN in) (ADJP (JJ particular))) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ artificial) (NN intelligence)) (PRN (-LRB- -LRB-) (NP (NNP AI)) (-RRB- -RRB-))))))))) (VP (VBZ is) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (JJ large) (NNS databases)) (PP (IN of) (NP (JJ medical) (NNS images))) (SBAR (WHNP (WDT which)) (S (VP (NN share) (NP (NNS images)) (PP (IN with) (NP (JJ other) (NNS researchers)))))))))) (. .))
(S (S (PP (IN Without) (NP (JJ such) (NNS databases))) (NP (NP (PRP it))) (VP (VBZ is) (RB not) (ADJP (JJ possible)) (S (VP (TO to) (VP (VB train) (NP (JJ generalisable) (NNP AI) (NN algorithms))))))) (, ,) (CC and) (S (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (NN time) (CC and) (NN funding)))) (VP (VBZ is) (VP (VBN spent) (S (VP (VBG collecting) (NP (JJR smaller) (NNS datasets)) (PP (IN at) (NP (JJ individual) (NN research) (NNS centres)))))))) (. .))
(S (NP (NP (DT The) (NNP OPTIMAM) (NN image) (NN database)) (PRN (-LRB- -LRB-) (NP (NNP OMI-DB)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN developed) (S (VP (TO to) (VP (VB overcome) (NP (DT these) (NNS barriers)))))))) (. .))
(S (NP (JJ OMI-DB)) (VP (NNS consists) (PP (IN of) (NP (NP (NP (JJ several) (JJ relational) (NNS databases)) (CC and) (NP (JJ cloud) (NN storage) (NNS systems))) (, ,) (VP (VBG containing) (NP (NP (NN mammography) (NNS images)) (CC and) (NP (VBN associated) (UCP (JJ clinical) (CC and) (JJ pathological)) (NN information))))))) (. .))
(S (NP (DT The) (NN database)) (VP (VBZ contains) (NP (NP (QP (IN over) (CD 2.5) (CD million)) (NNS images)) (PP (IN from) (NP (CD 173,319) (NNS women))) (VP (VBN collected) (PP (IN from) (NP (CD three) (NNP UK) (NN breast) (NN screening) (NNS centres)))))) (. .))
(S (NP (DT This)) (VP (VBZ includes) (NP (NP (NP (CD 154,832) (NNS women)) (PP (IN with) (NP (JJ normal) (NNS breasts)))) (, ,) (NP (NP (CD 6909) (NNS women)) (PP (IN with) (NP (JJ benign) (NNS findings)))) (, ,) (NP (NP (CD 9690) (NNS women)) (PP (IN with) (NP (JJ screen-detected) (NNS cancers)))) (CC and) (NP (NP (CD 1888) (NNS women)) (PP (IN with) (NP (JJ interval) (NNS cancers)))))) (. .))
(S (S (NP (NN Collection)) (VP (VBZ is) (ADJP (JJ on-going)))) (CC and) (S (S (NP (DT all) (NNS women)) (VP (VBP are) (VP (JJ followed-up)))) (CC and) (S (NP (PRP$ their) (JJ clinical) (NN status)) (VP (VBD updated))) (PP (VBG according) (PP (TO to) (NP (JJ subsequent) (NN screening) (NNS episodes))))) (. .))
(S (NP (NP (DT The) (NN availability)) (PP (IN of) (NP (NP (JJ prior) (VBG screening) (NNS mammograms)) (CC and) (NP (NN interval) (NNS cancers))))) (VP (VBZ is) (NP (NP (DT a) (JJ vital) (NN resource)) (PP (IN for) (NP (NNP AI) (NN development))))) (. .))
(S (NP (NP (NNS Data)) (PP (IN from) (NP (NNP OMI-DB)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shared) (PP (IN with) (NP (QP (IN over) (CD 30)) (NN research) (NNS groups) (CC and) (NNS companies))) (, ,) (PP (IN since) (NP (CD 2014)))))) (. .))
(S (NP (DT This) (JJ progressive) (NN approach)) (VP (VBZ has) (VP (VBN been) (ADJP (JJ possible)) (PP (IN through) (NP (NP (VBG sharing) (NNS agreements)) (PP (IN between) (NP (NP (DT the) (NN funder)) (CC and) (NP (VBD approved) (UCP (JJ academic) (CC and) (JJ commercial)) (NN research) (NNS groups)))))))) (. .))
(S (NP (NP (DT A) (NN research) (NN dataset)) (PP (JJ such) (IN as) (NP (DT the) (NNP OMI-DB)))) (VP (VBZ provides) (NP (NP (DT a) (JJ powerful) (NN resource)) (PP (IN for) (NP (NN research))))) (. .))
